Literature DB >> 25398793

Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification.

Marco Rastrelli1, Saveria Tropea2, Carlo Riccardo Rossi3, Mauro Alaibac4.   

Abstract

This article reviews epidemiology, risk factors, pathogenesis and diagnosis of melanoma. Data on melanoma from the majority of countries show a rapid increase of the incidence of this cancer, with a slowing of the rate of incidence in the period 1990-2000. Males are approximately 1.5-times more likely to develop melanoma than females, while according to other studies, the different prevalence in both sexes must be analyzed in relation with age: the incidence rate of melanoma is grater in women than men until they reach the age of 40 years, however, by 75 years of age, the incidence is almost 3-times as high in men versus women. The most important and potentially modifiable environmental risk factor for developing malignant melanoma is the exposure to ultraviolet (UV) rays because of their genotoxic effect. Artificial UV exposure may play a role in the development of melanoma. The most important host risk factors are the number of melanocytic nevi, familiar history and genetic susceptibility. A patient with a personal history of melanoma must be considered at greater risk for subsequent melanoma. Indeed approximately 1-8% of patients with prior history of melanoma will develop multiple primary melanomas. We herein review the dermatological diagnosis and classification of melanoma.
Copyright © 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Melanoma; classification; dermoscopy; diagnosis; epidemiology; pathogenesis; reflect confocal microscopy; review; risk factors

Mesh:

Year:  2014        PMID: 25398793

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  169 in total

Review 1.  Donor-Transmitted Melanoma: Is It Still Bothering Us?

Authors:  Leila Abdullayeva
Journal:  Curr Treat Options Oncol       Date:  2020-04-23

2.  Risk Factors of Subsequent Primary Melanomas in Austria.

Authors:  Christoph Müller; Judith Wendt; Sabine Rauscher; Raute Sunder-Plassmann; Erika Richtig; Ingrid Fae; Gottfried Fischer; Ichiro Okamoto
Journal:  JAMA Dermatol       Date:  2019-02-01       Impact factor: 10.282

Review 3.  Ca2+ as a therapeutic target in cancer.

Authors:  Scott Gross; Pranava Mallu; Hinal Joshi; Bryant Schultz; Christina Go; Jonathan Soboloff
Journal:  Adv Cancer Res       Date:  2020-07-09       Impact factor: 6.242

Review 4.  Model Systems for the Study of Malignant Melanoma.

Authors:  Randal K Gregg
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Primary malignant melanomas of the female lower genital tract: clinicopathological characteristics and management.

Authors:  Dongying Wang; Tianmin Xu; He Zhu; Junxue Dong; Li Fu
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

6.  Association Between Melanoma Risk and Height: A Narrative Review.

Authors:  Gino A Vena; Nicoletta Cassano; Stefano Caccavale; Giuseppe Argenziano
Journal:  Dermatol Pract Concept       Date:  2019-04-30

7.  Fibroblasts potentiate melanoma cells in vitro invasiveness induced by UV-irradiated keratinocytes.

Authors:  Njainday Pulo Jobe; Veronika Živicová; Alžběta Mifková; Daniel Rösel; Barbora Dvořánková; Ondřej Kodet; Hynek Strnad; Michal Kolář; Aleksi Šedo; Karel Smetana; Karolina Strnadová; Jan Brábek; Lukáš Lacina
Journal:  Histochem Cell Biol       Date:  2018-02-12       Impact factor: 4.304

Review 8.  The Role of Autophagy in the Resistance to BRAF Inhibition in BRAF-Mutated Melanoma.

Authors:  Xiao Liu; Jinfeng Wu; Haihong Qin; Jinhua Xu
Journal:  Target Oncol       Date:  2018-08       Impact factor: 4.493

9.  Trends in incidence and survival in patients with melanoma, 1974-2013.

Authors:  Gang Che; Bingjiang Huang; Zhinan Xie; Jingjing Zhao; Yan Yan; Jinna Wu; Huanhuan Sun; Haiqing Ma
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

10.  Use of Antihypertensive Drugs and Risk of Malignant Melanoma: A Meta-analysis of Observational Studies.

Authors:  Huilin Tang; Shuangshuang Fu; Suodi Zhai; Yiqing Song; Jiali Han
Journal:  Drug Saf       Date:  2018-02       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.